Follow this preprint
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Majhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
doi: https://doi.org/10.1101/2021.01.05.21249310
Now published in Journal of Pharmacy & Pharmaceutical Sciences doi: 10.18433/jpps32105
Ravikirti
1Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Patna, India
Roles: Additional Professor and Head
Ranjini Roy
2Department of General Medicine, AIIMS, Patna, India
Roles: Postgraduate Trainee
Chandrima Pattadar
2Department of General Medicine, AIIMS, Patna, India
Roles: Postgraduate Trainee
Rishav Raj
3Department of General Medicine, AIIMS, Patna
Roles: Postgraduate Trainee
Neeraj Agarwal
4Department of Community and Family Medicine, AIIMS, Bibi Nagar, India
Roles: Professor and Head
Bijit Biswas
5Department of Community and Family Medicine, AIIMS, Patna, India
Roles: Senior Resident
Pramod Kumar Majhi
6Department of Pharmacology, AIIMS, Patna, India
Roles: Assistant Professor and Head
Deependra Kumar Rai
7Department of Pulmonary Medicine, AIIMS, Patna, India
Roles: Additional Professor and Head
Shyama
3Department of General Medicine, AIIMS, Patna
Roles: Assistant Professor
Anjani Kumar
3Department of General Medicine, AIIMS, Patna
Roles: Assistant Professor
Asim Sarfaraz
9Department of Microbiology, AIIMS, Patna
Roles: Assistant Professor

Data Availability
The data can be made available by the corresponding author on rasonable request.
Posted January 09, 2021.
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
Ravikirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Majhi, Deependra Kumar Rai, Shyama, Anjani Kumar, Asim Sarfaraz
medRxiv 2021.01.05.21249310; doi: https://doi.org/10.1101/2021.01.05.21249310
Now published in Journal of Pharmacy & Pharmaceutical Sciences doi: 10.18433/jpps32105
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3043)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4773)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3029)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4545)
- Nursing (242)
- Nutrition (671)
- Oncology (2365)
- Ophthalmology (667)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7137)
- Radiology and Imaging (1588)
- Respiratory Medicine (941)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (505)
- Toxicology (63)
- Transplantation (218)
- Urology (187)